{
  "main_header": {
    "sid": 1003813,
    "name": "Sudarshan Pharma",
    "stock_name": "Sudarshan Pharma",
    "full_name": "Sudarshan Pharma Industries Ltd",
    "name_url": "stocks-analysis/sudarshan-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "29.53",
    "chg": -0.6,
    "chgp": "-1.99%",
    "dir": -1,
    "prev_price": "30.13",
    "mcapval": "725.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543828,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE00TV01023",
    "curr_date": "Apr 11, 12:37 PM",
    "curr_time": "00:09 AM",
    "bse_nse_vol": 16000,
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sudarshan-pharma-1003813-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "1003813",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/sudarshan-pharma-industries-1003813"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
      "datetime": "03-Apr-2025",
      "details": "This is to inform you that the Company ahs acquired 209100 equity shares of Ishwari Healthcare Private Limited (51.00% of paid up equity share capital) at a revised consideration of Rs.15000000/- @ Rs.71.73/- per share. More details are provided in the letter to the BSE.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
      "datetime": "01-Apr-2025",
      "details": "The Board of Directors of the Company at their meeting held on 31-03-2025 (1) rescinded its decision to appoint Mr. Manoj Lodha as Executive Director & Chief Financial Officer upon his withdrawal of consent and (2) Mr. Sachin Mehta to continue as Joint Managing Director & Chief Financial Officer of the Company. (Details given in the files attached).",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "31-Mar-2025",
      "details": "This is to inform you that the Trading Window of the Company shall remain closed with effect from 1/April/2025 untill the expiry of 48 hours after the declaration of financial results for the financial year ended 31/March/2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sudarshan Pharma Industries Ltd has declared <strong>3%</strong> dividend, ex-date: 25 Aug 23",
          "dt": "2023-08-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sudarshan Pharma Industries Ltd has announced <strong>1:10</strong> stock split, ex-date: 22 Nov 24",
          "dt": "2024-11-22",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News